↓ Skip to main content

Developing and financing neglected disease vaccines in our new era of “blue marble health” and the anthropocene epoch

Overview of attention for article published in Vaccine, March 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Developing and financing neglected disease vaccines in our new era of “blue marble health” and the anthropocene epoch
Published in
Vaccine, March 2017
DOI 10.1016/j.vaccine.2017.02.002
Pubmed ID
Authors

Peter J. Hotez

Abstract

New findings of widespread neglected diseases among the poor living in wealthy group of 20 (G20) economies and the concept of "blue marble health" offer innovative mechanisms for financing urgently new vaccines, especially for vector-borne neglected tropical diseases (NTDs). This approach could complement or parallel a recently suggested global vaccine development fund for pandemic threats.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 41 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 27%
Student > Bachelor 6 15%
Student > Ph. D. Student 5 12%
Student > Master 4 10%
Lecturer 3 7%
Other 5 12%
Unknown 7 17%
Readers by discipline Count As %
Medicine and Dentistry 9 22%
Immunology and Microbiology 4 10%
Mathematics 3 7%
Environmental Science 2 5%
Agricultural and Biological Sciences 2 5%
Other 9 22%
Unknown 12 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2020.
All research outputs
#3,062,900
of 25,382,440 outputs
Outputs from Vaccine
#2,721
of 16,511 outputs
Outputs of similar age
#54,374
of 323,707 outputs
Outputs of similar age from Vaccine
#51
of 222 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,511 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 323,707 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.